ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD  |  Issue: December 2025  |  November 14, 2025

CHICAGO—At a session of ACR Convergence 2025, attendees explored several topics from the vantage of complementary and alternative medicine, many of which could easily be incorporated into a more traditional medical approach.

Putting Out the Fire of Inflammation

Dr. Nisha Manek

The speaker, Nisha Manek, MD, FACP, FRCP, is a telemedicine integrative rheumatologist with Avel eCare and is based in Yorba Linda, Calif. She has added to her conventional rheumatology expertise with various kinds of training in complementary medicine, such as through the University of Arizona’s Fellowship in Integrative Medicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Manek urged her colleagues to pursue alternative avenues to “fight the fire” of their patients’ inflammation. She advocated for finding ways to address inflammation at its origin and not just through standard therapies.

Diet

Dr. Manek shared stories of some patients whose symptoms remarkably improved after changing some simple components of their diet. However, she also noted that making big changes can be challenging for patients. “Our patients don’t choose to eat badly. The reality is they’re surrounded by processed foods,” she said. “That’s what’s easy and accessible.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Simple questions about about diet are not a standard part of the diet are not a standard part of the rheumatology medical history and review of systems, Dr. Manek pointed out; further, taking time to ask such questions may not be billable. “A question like, ‘What did you eat for breakfast today?’ may look deceptively simple, yet it is concrete and modifiable. Find out what your patients are eating,” she urged. 

Mediterranean Diet & Ultra-Processed Foods

Dr. Manek noted the ACR recommends a Mediterranean diet, which emphasizes intake of vegetables, fruits, whole grains, nuts, seeds and olive oil, with moderate portions of dairy, fish, poultry, eggs and beans. Importantly, the diet also limits added sugars, refined carbohydrates and highly processed foods.1

Zoning in on this latter category, Dr. Manek especially warned that many foods can contain additives not optimal for controlling inflammation. Such foods are also often high in sugar, fat and salt.

Generally speaking, the rheumatology community agrees that large amounts of highly processed “junk foods” can worsen patients’ health. For example, two recent studies found that ultra-processed foods may increase the risk of rheumatoid arthritis (RA).2,3

Dr. Manek also recommended limiting the use of factory-produced seed oils, such as soybean, corn, cottonseed, canola, grapeseed, sunflower, safflower and generic vegetable oil, usually some blend of these. This is consistent with current health trends positing their role in inflammation, perhaps due to the way these oils are processed or their omega-6 content. Although this is not in line with much of the current expert opinion on the subject, such oils are quite common in ultra-processed foods, so limiting them in that setting may be beneficial.4,5

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAComplementary and Alternative TherapiesDietstress managementsupplements

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    What Diet to Recommend to Patients with Rheumatoid Arthritis?

    November 1, 2013

    With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

    Diet May Help Reduce Inflammation in RA

    March 27, 2023

    In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

    2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response

    March 15, 2016

    SAN FRANCISCO—Inflammation can be either acute or chronic, and it’s the inflammatory responses that don’t shut down normally, or resolve, that cause tissue damage in rheumatic disease. “Resolution bridges the gap between acute inflammation and adaptive immunity,” said Derek W. Gilroy, PhD, head of the Centre for Clinical Pharmacology and Professor of Immunology at University…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences